Form 4 for BDSX BIODESIX INC
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-10 · accession 0000905148-25-003931 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-13 | 2025-11-10 | BDSX | O'Kane Kieran | Chief Commercial Off | M - OptEx | — | +75 | 7,387 | +1% | — |
| D | 2025-11-13 | 2025-11-10 | BDSX | O'Kane Kieran | Chief Commercial Off | S - Sale+OE | $7.62 | -25 | 7,362 | -0.3% | -$190.50 |
| D | 2025-11-13 | 2025-11-10 | BDSX | O'Kane Kieran | Chief Commercial Off | M - OptEx | $0.00 | -75 | 73 | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | M | A | 75 | — | 7,387 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split"). (F2) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F3) Includes 309 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025. |
| 2 | Common | Common Stock | 2025-11-10 | S | D | 25 | $7.62 | 7,362 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-11-10 | M | D | 75 | $0.00 | 73 | D | — · — to — | 75 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split"). (F2) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F5) These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. |